FDA Approved: * March 1, 2010 Pharm Company: *BARR Category:Cancer
Temozolomide (TMZ), sold under the brand name Temodar among others, is a medication used to treat some brain tumors such as glioblastoma multiforme or anaplastic astrocytoma.[3][4] It is taken by mouth or via intravenous infusion.[3][4]
The most common side effects with temozolomide are nausea, vomiting, constipation, loss of appetite, alopecia (hair loss), headache, fatigue, convulsions (seizures), rash, neutropenia or lymphopen...
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion